First Week of April 19th Options Trading For Array BioPharma (ARRY)

Investors in Array BioPharma Inc. ( ARRY) saw new options begin trading this week, for the April 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARRY options chain for the new April 19th contracts and identified the following put contract of particular interest.

The put contract at the $5.00 strike price has a current bid of 30 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $5.00, but will also collect the premium, putting the cost basis of the shares at $4.70 (before broker commissions). To an investor already interested in purchasing shares of ARRY, that could represent an attractive alternative to paying $5.05/share today.

Because the $5.00 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 57%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 6.00% return on the cash commitment, or 42.15% annualized — at Stock Options Channel we call this the YieldBoost.

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Below is a chart showing the trailing twelve month trading history for Array BioPharma Inc., and highlighting in green where the $5.00 strike is located relative to that history:

Loading+chart++2014+TickerTech.com

The implied volatility in the put contract example above is 64%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $5.05) to be 55%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.

If you liked this article you might like

An Aggressive Trade in Array Biopharma

An Aggressive Trade in Array Biopharma

This Isn't a Rally: Cramer's 'Mad Money' Recap (Monday 12/4/17)

This Isn't a Rally: Cramer's 'Mad Money' Recap (Monday 12/4/17)

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Mirati Skyrockets On Positive Data - Biotech Movers

Mirati Skyrockets On Positive Data - Biotech Movers